We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Well-Timed Referral Needed for Intestinal Transplant

By HospiMedica staff writers
Posted on 02 Aug 2006
Timely referral for intestinal transplantation--a life-saving procedure for patients with irreversible intestinal failure--can reduce mortality rates, according to a new study.

Researchers from nine European countries investigated patient candidacy and physician attitudes toward intestinal transplantation (ITx) among centers that participated in previous European surveys on home parenteral nutrition (HPN). More...
The patients on HPN for benign intestinal failure (IF) were evaluated by a structured questionnaire. Candidacy was assessed by the U.S. Medicare and American Transplantation Society (ATS) criteria, and categorized as one of the following: (1) life-threatening HPN complications, (2) high risk of death because of gastrointestinal disease, (3) IF with high morbidity or patient HPN refusal. Physicians judged candidacy as immediate or potential.

Forty-one centers from nine countries enrolled 688 adults and 166 pediatric patients; 70% of patients were from five countries that collected 60-100% of their HPN patients. Candidacy was 15.7% in adults and 34.3% in pediatrics. Immediate candidacy was required for 14.8% of adult and 15.8% of pediatric candidates (less than 50% of the candidates because of HPN-related liver failure). Among the major contributing countries, candidacy ranged 0.3-0.8 per million inhabitants for adults and 0.9-2 per million inhabitants for pediatric (under 18 years old) candidates. The rate of candidacy and the indications for ITx candidacy differed greatly among age groups and HPN centers, but within countries candidacy was more homogeneous. Physicians had a generally reserved attitude toward ITx. The results were published in the July 2006 issue of the American Journal of Gastroenterology

"Irreversible intestinal failure is a condition which has a deep impact on the patient's health and quality of life; it requires great organizational and economical efforts by the national health care system and professionals,” said lead author Dr. Loris Pironi, an associate professor of internal medicine at the University of Bologna (Italy).

Knowing the criteria for which transplantation may be necessary will enable doctors to refer patients when needed. Patient referrals for transplantation may come too late, and this may increase mortality rates among those on the waiting list.



Related Links:
University of Bologna

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.